Cutaneous Mature T-Cell and NK-Cell Neoplasm

Cutaneous Mature T-Cell and NK-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

329 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–66 of 66 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00007345	Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma	completed	Phase 2	131	National Cancer Institute (NCI)NIH	2	May 16, 2017	clinicaltrials
NCT00091559	Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001)	completed	Phase 2	74	Merck Sharp & Dohme LLCINDUSTRY	0	Apr 5, 2017	clinicaltrials